Advanced Therapies Europe 2020

29TH - 30TH SEPTEMBER 2020



Catherine Cancian

Catherine Cancian

VP, Pharmaceutical Operations, GenSight Biologics
Catherine Cancian has been the Vice President of Pharmaceutical Operations at GenSight since April 2017, supporting the Pharmaceutical Development programs from preclinical to Phase III clinical studies and commercialization through strategic alliance management for manufacturing & supply operations. 

Catherine has over 20 years’ experience in manufacturing operations and process improvement in biotechnology companies. She served at various positions at Sanofi Pasteur, including management level responsibilities in Manufacturing, Quality & CMC compliance, and project management, leading multifunctional project teams in the New Drug Application filing and marketing approval. From 2015 to 2017, she served at Genethon Bioproduction to lead industrialization projects for gene therapy vectors. 

Catherine received a master’s degree in Neurosciences from Pierre & Marie Curie University (Paris), an Engineering Degree in Biotechnologies from UTC and a master’s degree in Business and Management of Strategic Units from HEC (Paris).
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd